Differences in the expression of five senescence markers in oral cancer, oral leukoplakia and control samples in humans

Oncology Letters

Volumn 3, Issue 6, 2012, Pages 1319-1325

  Bascones Martínez, Antonio ^a   López Durán, Mercedes ^a   Cano Sánchez, Jorge ^a   Sánchez Verde, Lydia ^b   Díez Rodríguez, Ana ^b   Aguirre Echebarría, Pablo ^c   Álvarez Fernández, Emilio ^c   González Moles, Miguel Angel ^d   Bascones Ilundain, Jaime ^a   Muzio, Lorenzo Lo ^e,f   Campo Trapero, Julián ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Structural Biology and Biocomputing Programme   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d UNIVERSITY OF GRANADA   (Spain)

^e UNIVERSITY OF FOGGIA   (Italy)

^f REFERRAL CANCER CENTER OF BASILICATA   (Italy)

Author keywords

Cyclin D1; Maspin; MDM2; Oral cancer; Oral leukoplakia; P53; Rb; Senescence

Indexed keywords

CYCLIN D1; MASPIN; PROTEIN MDM2; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER SURVIVAL; FEMALE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; MOUTH MUCOSA; ORAL SQUAMOUS CELL CARCINOMA; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; TISSUE MICROARRAY;

EID: 84859455413     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.649     Document Type: Article

References (24)

1. Hayflick L and Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 25: 585-621, 1961.
2. Ohtani N, Mann DJ and Hara E: Cellular senescence: its role in tumor suppression and aging. Cancer Sci 100: 792-797, 2009.
3. Collado M, Gil J, Efeyan A, Guerra C, Schuhmacher AJ, Barradas M, et al: Tumour biology: senescence in premalignant tumours. Nature 436: 642, 2005.
4. Nickoloff BJ, Lingen MW, Chang BD, Shen M, Swift M, Curry J, et al: Tumor suppressor maspin is up-regulated during keratinocyte senescence, exerting a paracrine antiangiogenic activity. Cancer Res 64: 2956-2961, 2004.
5. Parkin DM, Pisani P and Ferlay J: Global cancer statistics. CA Cancer J Clin 49: 33-64, 1999.
6. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, et al: Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature 436: 725-730, 2005.
7. Michaloglou C, Vredeveld LC, Soengas MS, et al: BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature 436: 720-724, 2005.
8. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, et al: Oncogene-induced senescence as an initial barrier in lymphoma development. Nature 436: 660-665, 2005.
9. Vered M, Allon I and Dayan D: Maspin, p53, p63, and Ki-67 in epithelial lesions of the tongue: from hyperplasia through dysplasia to carcinoma. J Oral Pathol Med 38: 314-320, 2009.
10. Soni S, Kaur J, Kumar A, Chakravarti N, Mathur M, Bahadur S, et al: Alterations of Rb pathway components are frequent events in patients with oral epithelial dysplasia and predict clinical outcome in patients with squamous cell carcinoma. Oncology 68: 314-325, 2005.
11. Itahana K, Dimri G and Campisi J: Regulation of cellular senescence by p53. Eur J Biochem 268: 2784-2789, 2001.
12. Shangary S, Qin D, McEachern D, Liu M, Miller RS, Qiu S, et al: Temporal activation of p53 by a specific MDM2 inhibitor is selectively toxic to tumors and leads to complete tumor growth inhibition. Proc Natl Acad Sci USA 105: 3933-3938, 2008.
13. Lavertu P, Adelstein DJ, Myles J and Secic M: P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy. Laryngoscope 111: 1878-1892, 2001.
14. Tu HF, Chen HW, Kao SY, Lin SC, Liu CJ and Chang KW: MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. Radiother Oncol 87: 243-252, 2008.
15. Huang SF, Chen IH, Liao CT, Wang HM, Liou SH, and Hsieh LL. Combined effects of MDM2 SNP 309 and p53 mutation on oral squamous cell carcinomas associated with areca quid chewing. Oral Oncol 45: 16-22, 2009.
16. Campo-Trapero J, Cano-Sánchez J, Palacios-Sánchez B, Sánchez-Gutiérrez JJ, González-Moles MA and Bascones-Martínez A: Update on molecular pathology in oral cancer and precancer. Anticancer Res 28: 1197-1205, 2008.
17. El-Naggar AK, Lai S, Clayman GL, Zhou JH, Tucker SA, Myers J, et al: Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. Hum Pathol 30: 1013-1018, 1999.
18. Liu HS, Lu HH, Lui MT, Yu EH, Shen W, Chen YP, et al: Detection of copy number amplification of cyclin D1 (CCND1) and cortactin (CTTN) in oral carcinoma and oral brushed samples from areca chewers. Oral Oncol 45: 1032-1036, 2009.
19. Myo K, Uzawa N, Miyamoto R, Sonoda I, Yuki Y and Amagasa T: Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM stage I and II squamous cell carcinoma of the oral cavity. Cancer 104: 2709-2716, 2005.
20. De Vicente JC, Herrero-Zapatero A, Fresno MF and López-Arranz JS: Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Oral Oncol 38: 301-308, 2002.
21. Sathyan KM, Nalinakumari KR, Abraham T and Kannan S: CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma. Oral Oncol 44: 689-697, 2008.
22. Marioni G, Gaio E, Giacomelli L, Bertolin A, D'Alessandro E, Stramare R, et al: Maspin subcellular localization and expression in oral cavity squamous cell carcinoma. Eur Arch Otorhinolaryngol 265: S97-104, 2008.
23. Cho JH, Kim HS, Park CS, Kim JK, Jung KY, Shin BK, et al: Maspin expression in early oral tongue cancer and its relation to expression of mutant-type p53 and vascular endothelial growth factor (VEGF). Oral Oncol 43: 272-277, 2007.
24. Yasumatsu R, Nakashima T, Hirakawa N, Kumamoto Y, Kuratomi Y, Tomita K, et al: Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck 23: 962-966, 2001.